Eleftha Trastuzumab 150 Mg Injection

Product Description

Eleftha 440mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Powerful Therapy for HER2-Positive Cancers

Eleftha Trastuzumab is a targeted antineoplastic monoclonal antibody therapy tailored for individuals battling HER2-positive metastatic breast or gastric cancers. By interfering with the HER2 protein, this treatment disrupts the signals that promote tumor cell growth, providing an essential therapy for selected cancer patients.


Biological Origin and Stringent Quality

Eleftha is produced using advanced biotechnology methods, ensuring a high-quality biological product. Each vial contains 150 mg of pure Trastuzumab, offered as a white to pale yellow lyophilized powder, and is strictly for single use. Rigorous manufacturing standards help deliver efficacy as well as patient safety.


Usage, Storage, and Handling

The injection must be reconstituted with sterile water before administration, and administered as an IV infusion by healthcare professionals in a clinical setting. It's crucial to store Eleftha between 2C and 8C, avoiding freezing, to preserve its therapeutic effectiveness. Always follow your oncologist's guidance for dosage and administration frequency.